Access To Medicine Foundation
  • Who we are
  • What we do
  • Impact
  • Insights & resources
  • News & events
  • Donate
Donate

Who we are

An independent non-profit organisation accelerating progress toward global health equity.

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports

What we do

We catalyse progress toward equitable access to essential medicines in low- and middle-income countries through our work across diverse research areas.

  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care

Impact

Discover how our work drives real-world progress on access to medicine.

  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us

Insights & resources

Discover our evidence-based research, insights and other changemaking tools.

  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens

News & events

Stay informed on our latest events, collaborations, engagements, and Foundation news.

  • News
  • Events & engagements
  • In the media

Follow us

Often searched

Index ranking

Vacancies

10 year analysis

Follow us

  • About us
  • How we drive change
  • Our strategy 2022 - 2026
  • Governance
  • Team
  • Funders
  • Annual reports
  • R&D-based pharma companies
  • Medical gas companies
  • Generic medicine manufacturers
  • Diagnostics companies
  • Vaccine manufacturers
  • Antimicrobial resistance
  • Diabetes care
  • Our achievements
  • Voices of our community
  • How we drive change
  • Partner with us
  • Research hub
  • Company profiles & report cards
  • Access insights
  • The Health Equity podcast
  • Health Equity through Her Lens
  • News
  • Events & engagements
  • In the media

Bowen Gu to speak at RI Americas 2018

On 6 December, Bowen Gu, Investor Engagement Researcher at the Access to Medicine Foundation, will speak at the RI Americas Conference in New York, USA.

Date

06 December 2018

Bowen will join a panel discussion titled 'Investing in short-term profits and long-term risks - is the pharmaceutical industry business model destroying or creating value for long-term investors?' She will speak about the key findings from the 2018 Access to Medicine Index and the Access to Medicine Foundation’s investor engagement programme.

The RI Americas is an annual gathering of sustainable business and investment professionals. This is the tenth year that it is being held in New York. The conference will engage with North America’s largest investors on key responsible investment issues affecting local markets and the rest of the world.

2018 Access to Medicine Index launch events
Also taking place in New York, on 7 December, the Access to Medicine Foundation will host the launch of the 2018 Access to Medicine Index with Goldman Sachs. This event forms part of a series of investor launch events taking place in London, NYC and Tokyo.

Investor engagement at the Access to Medicine Foundation
82 institutional investors, collectively managing assets in excess of $11 trillion, have already committed to using the Access to Medicine Index in their investment analyses and engagements with companies, by signing the Index investor statement. The Sustainability Accounting Standard Board (SASB) makes explicit reference to the framework of the Access to Medicine Index in the recently published SASB Standard for the Biotechnology & Pharmaceuticals industry. 


Access to Medicine Foundation

Subscribe to our newsletter

Vacancies FAQs Contact us

Follow us

Access to Medicine Foundation is funded by

Terms & conditions Privacy & cookie policy Disclaimer

Copyright 2004 - 2026 Access to Medicine Foundation - All Rights Reserved